These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20052915)

  • 1. [Protective activity of panavir in experimental rabies infection].
    Gribencha SV; Litvin AA; Kokhnovich MA; Sergienko VI; Stovbun SV; Iakimuk PV; Bezmen VG
    Antibiot Khimioter; 2009; 54(5-6):31-6. PubMed ID: 20052915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antiviral activity of RNAse Bacillus intermedius in experiments with mice preinfected with street rabies virus].
    Gribencha SV; Potselueva LA; Barinskiĭ IF; Balandin TG; Deev SM; Leshchinskaia IB
    Vopr Virusol; 2004; 49(6):38-41. PubMed ID: 15597960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increasing the effectiveness of immunotherapy of rabies by using rifampicin in experimental studies].
    Zubovich IK; Mishaeva NP; Votiakov VI
    Antibiot Khimioter; 1991 Oct; 36(10):31-3. PubMed ID: 1725249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antiviral activity of the peptide immunomodulator "Gepon" in experimental models of street rabies virus].
    Gribencha SV; Kholms RD; Ataullakhanov RI; Barinskiĭ IF
    Vopr Virusol; 2003; 48(4):40-4. PubMed ID: 12945207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune response during the course of chronic experimental rabies].
    Gribencha SV; Vanag KA; Barinskiĭ IF
    Vopr Virusol; 1981; (5):601-4. PubMed ID: 7336685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Panavir on influenza A virus reproduction].
    Prokudina EN; Galegov GA; Semenova NP; Grigor'eva TA; Kalinina TS; Litvin AA; Stovbun SV; Sergienko VI
    Antibiot Khimioter; 2006; 51(6):7-10. PubMed ID: 17523415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity of rabies virus-exposed macrophages.
    Nazé F; Suin V; Lamoral S; Francart A; Brochier B; Roels S; Mast J; Kalai M; Van Gucht S
    Microbes Infect; 2013 Feb; 15(2):115-25. PubMed ID: 23159243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination.
    Ma X; Niezgoda M; Blanton JD; Recuenco S; Rupprecht CE
    Vaccine; 2012 Aug; 30(36):5358-62. PubMed ID: 22749835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of vampire bats using recombinant vaccinia-rabies virus.
    Aguilar-Setién A; Leon YC; Tesoro EC; Kretschmer R; Brochier B; Pastoret PP
    J Wildl Dis; 2002 Jul; 38(3):539-44. PubMed ID: 12243138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of human interferon to rabies virus-infected monkeys after exposure.
    Hilfenhaus J; Weinmann E; Majer M; Barth R; Jaeger O
    J Infect Dis; 1977 May; 135(5):846-9. PubMed ID: 404370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus.
    Tesoro-Cruz E; Calderón-Rodríguez R; Hernández-González R; Blanco-Favéla F; Aguilar-Setién A
    Vet Res; 2008; 39(2):16. PubMed ID: 18215393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo studies of pathogenic, immunogenic and protective properties of Roma strain rabies virus recovered from a persistently infected BHK21 cell line.
    Grassi M; Wandeler AI; Gerber H; Peterhans E
    Microbiologica; 1987 Apr; 10(2):217-27. PubMed ID: 3587068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiviral activity of panavir in experimental Measles virus infection in cell cultures].
    Markushin SG; Litvin AA
    Antibiot Khimioter; 2009; 54(1-2):14-6. PubMed ID: 19499711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of antibodies against rabies in wild boars.
    Vengušt G; Hostnik P; Cerovšek M; Cilenšek P; Malovrh T
    Acta Vet Hung; 2011 Mar; 59(1):149-54. PubMed ID: 21354950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.